Analysis of Peptone Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global peptone market is estimated to be worth US$ 154.8 million in 2024. The market is projected to register a CAGR of 4.0% through 2034. It is predicted that by the time the forecast period ends, the market value is set to have reached US$ 228.8 million.
Key Market Growth Drivers
The rising use of liquid protein for the growth of microorganisms and for experiments related to microorganisms is fueling the demand for peptones. The use of peptones in cell culture media is crucial for research studies related to microorganisms. Thus, peptone is making its way into labs in an increasing number of batches.
Cell culture media testing is on the rise as a result of the growth in the clinical microbiology sector. As the number of diseases resulting from bacteria and other microorganisms continues to grow, there is felt a need to study them better, driving more attention to their testing. Thus, the clinical microbiology sector is acquiring a positive outlook, which in turn is benefitting the peptone market.
The need to curb the spread of diseases is being felt by governments, and thus, there is public encouragement for cell culture growth. Governments are making pathways clear for the development of biopharmaceutical companies as well as developing a culture where startups can thrive. Thus, public investment and interest are aiding the peptone market.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 154.8 million |
| Forecasted Market Value (2034F) | US$ 228.8 million |
| Global Market Growth Rate (2024 to 2034) | 4.0% CAGR |
| Plant Segment Growth Rate (2024 to 2034) | 4.1% |
| Protein Hydrolysates Segment Growth Rate (2024 to 2034) | 3.8% |
| North America Market Share (2024) | 32.7% |
| East Asia Market Share (2024) | 14.7% |
| Key Companies Profiled | Hi-Media Laboratories; Thermo Fisher Scientific, Inc.; Merck KGaA; Hardy Diagnostics; Solabia Group; Kerry Inc.; Organotechnie; Biotecnica; Nu-Tek BioScience LLC; Tatua; Krishna Enzytech Pvt. Ltd.; Titan Biotech; Suvidhinath Laboratories; Jeevan Biotech |
“Rising Demand for Peptone Extraction from Non-animal Sources”
With the rising trend of people being averse to animal cruelty, peptone extracted from non-animal sources is increasing in popularity. While peptone extraction from animal sources is still the norm, yeast, and plants are also used as sources for peptone. Thus, the extraction of peptone not being tied down to animal sources is driving the market forward.
“Novel Sources of Peptone Extraction Fueling Market Demand”
Vendors in the market are on the lookout for new sources of peptones, whether animal-based or not. Boso fish is one such example of a new source for peptone extraction. Thus, the avenues for obtaining the product are ever-expanding.
“Risk of Contamination, High Cost of Extraction, and the Absence of Qualified Personnel”
Cell culture media requires minute observation for successful growth. There is a risk of one or more factors going wrong in the cultivation of cell culture media and the batch being spoiled. Mishandling of peptone, whether during supply or during the application itself, has the potential to ruin cell culture growth.
Sometimes, the work is handed over to non-experts, such as lab assistants or students, which runs the risk of spoiling the culture. Apart from mishandling, the culture may be contaminated due to the inherent fault of the peptone itself. Animal-derived peptone especially runs the risk of being low-quality and contaminated.
Maintaining labs and employing research experts require considerable investment. Thus, cell culture media growth is a costly business, which adversely affects the growth of products associated with it, including peptone. Therefore, the market players have to navigate through several obstacles in their quest to expand the demand for peptone.
North America holds a considerable portion of the market share. In 2024, the market value in North America is likely to be US$ 51.0 million, with a share of 32.7%. The market is expected to register a CAGR of 3.1% in North America over the forecast period. The valuation in North America is expected to reach US$ 68.0 million, with the industry share being 29.9% by 2034.
East Asia is set to leave North America behind in terms of anticipated growth over the forecast period. The industry share for East Asia is estimated to be 14.7%, with a valuation of US$ 23.0 million in 2024. The CAGR for the market over the forecast period is anticipated to be 5.2%. The valuation of the market in East Asia is expected to be US$ 38.0 million, with an increased market share of 16.5% by 2034.
“Diverse Flora of Mexico and the Rising Popularity of Microbiology Aid the Market in Mexico”
| Attribute | Details |
|---|---|
| Market Value in 2024 | US$ 3.0 million |
| CAGR (2024 to 2034) | 5.7% |
The peptone market’s value in Mexico is anticipated to be US$ 3.0 million in 2024. The market in Mexico is expected to register a CAGR of 5.7% from 2024 to 2034. The market value is projected to reach US$ 5.0 million by the end of the forecast period.
Mexico is known for the presence of diverse plant life. The vast array of plants helps in the generation of peptone and also allows producers to look for new extraction sources, which also benefits the market for peptones in Mexico.
“Positive Outlook Towards Microbiological Research is Helping the Growth of the Market in South Korea”
| Attribute | Details |
|---|---|
| Market Value in 2024 | US$ 3.0 million |
| CAGR (2024 to 2034) | 6.8% |
South Korea is set to be one of the most promising Asian countries for peptone. The market value of peptone in South Korea for 2024 is marked at US$ 3.0 million. The market is expected to register a promising CAGR of 6.8% in South Korea over the forecast period, reaching a valuation of US$ 6.0 million by 2034.
South Korea has advanced research facilities and labs, which facilitate the growth of the microbiology sector. The growth of the microbiology and biotech culture in South Korea is fueling the demand for peptones.
Animals are considered the primary source of peptones. In 2024, animal extraction is expected to account for 56.6% of the market share by source. Plant extraction is expected to be the runner-up, with a share of 31.9% in 2024.
Protein hydrolysates dominate the product segment. In 2024, protein hydrolysates are expected to account for 76.5% of the industry share. The runner-up spot is taken up by extracts, with an anticipated 14.0% share in 2024.
“Animal Extraction of Peptones is Cost-efficient”
| Attribute | Details |
|---|---|
| Market Share in 2024 | 56.6% |
Animal extraction is expected to contribute to 56.6% of the industry share by source in 2024. Through 2034, the product is expected to progress at a CAGR of 3.8%. By the end of the forecast period, the share of animal extraction is expected to be 55.8%.
Animals are the predominant source of peptone. The microorganisms that grow in cell media culture feed on animal-sourced peptone well. With animal extraction having a long history, the process has also become refined. As a result, the animal extraction of peptone has become a cost-efficient process. The discovery of newer types of animals that can act as sources of peptone is also stimulating the animal segment growth.
However, the demand for non-animal sources of peptone is also growing. With trends in animal preservation, non-animal sources are being preferred by a considerable portion of research institutes. Plant as a source is expected to grow at a CAGR of 4.1% throughout the forecast period and contribute to an enhanced market share of 32.2% in 2034.
Many of the top-end companies enter into agreements and partnerships with local peptone suppliers to boost their market presence. Western companies are looking to tap into the boom in research facilities in the Asia Pacific. Thus, collaborations between Eastern and Western market players are common. As a result, the nature of the market is geographically diverse.
Some of the key players in the market include Hi-Media Laboratories, Thermo Fisher Scientific, Inc., Merck KGaA, Hardy Diagnostics, Solabia Group, Kerry Inc., Organotechnie, Biotecnica, Nu-Tek BioScience LLC, Tatua, Krishna Enzytech Pvt. Ltd., Titan Biotech, Suvidhinath Laboratories, and Jeevan Biotech.
Recent Developments
What is the Estimated Valuation for the Peptone Market in 2024?
The peptone market is likely to be valued at US$ 154.8 million in 2024.
What is the Demand Forecast for Peptones by 2034?
The demand for peptones is projected to reach a market value of US$ 228.8 million by the end of 2034.
What is the Adoption Projection for Peptones through 2034?
The adoption of peptones is projected to rise at a CAGR of 4.0% through 2034.
What is the Most Common Source of Peptones?
Animals are the most common source of peptone in the market, with an anticipated market share of 56.6% in 2024.
Which are the Prominent Companies in the Peptone Market?
Hi-Media Laboratories, Thermo Fisher Scientific, Inc., Merck KGaA, and Hardy Diagnostics are some of the prominent companies in the market.
Peptone Market